Literature DB >> 3940615

Carcinoma of the cervix, stage III. Results of radiation therapy.

G S Montana, W C Fowler, M A Varia, L A Walton, Y Mack, L Shemanski.   

Abstract

From April 1969 through December 1980, 203 patients with Stage III epidermoid carcinoma of the cervix were treated with radiation therapy with curative intent. The disease-free survival at 2, 5, and 10 years was 50%, 33%, and 27%, respectively. The survival was better for patients with Stage IIIB disease than for those with Stage IIIA disease. Eighty-eight patients were treated with external beam therapy only, and 115 received external beam and brachytherapy. The disease-free survival was better for the combination therapy group initially, but this difference was not sustained beyond 5 years. One hundred eight patients experienced recurrence within the irradiated field, for a locoregional recurrence rate of 53%. Twenty-seven patients had complications (13%). The complications were mild in 13 patients, moderate in 4 patients, and severe in 10 patients. A study was made of the relationship of the dose to Point A and the occurrence of complications. Similar analyses were made of the bladder and rectal doses and the subsequent occurrence of urinary and intestinal complications. In these analyses, the mean dose to Point A and the critical organs was higher for the groups of patients with complications than for those patients without complications. This relationship was also observed when the patients were stratified for treatment with either external beam plus brachytherapy or external beam therapy alone.

Entities:  

Mesh:

Year:  1986        PMID: 3940615     DOI: 10.1002/1097-0142(19860101)57:1<148::aid-cncr2820570130>3.0.co;2-7

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  18 in total

Review 1.  Current opinion in cervix carcinoma.

Authors:  Silvia Rodríguez Villalba; Carmen Díaz-Caneja Planell; José Manuel Cervera Grau
Journal:  Clin Transl Oncol       Date:  2011-06       Impact factor: 3.405

Review 2.  Brachytherapy in Gynecologic Cancers: Why Is It Underused?

Authors:  Kathy Han; Akila N Viswanathan
Journal:  Curr Oncol Rep       Date:  2016-04       Impact factor: 5.075

3.  [Rectal toxicity prediction based on accurate rectal surface dose summation for cervical cancer radiotherapy].

Authors:  Jia-Wei Chen; Hai-Bin Chen; Qiang He; Yu-Liang Liao; Xin Zhen
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-12-20

4.  [Prediction of rectal toxicity of radiotherapy for prostate cancer based on multi-modality feature and multi-classifiers].

Authors:  Qiang He; Xuetao Wang; Xin Li; Xin Zhen
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-08-30

5.  The quality of cervical cancer brachytherapy implantation and the impact on local recurrence and disease-free survival in radiation therapy oncology group prospective trials 0116 and 0128.

Authors:  Akila N Viswanathan; Jennifer Moughan; William Small; Charles Levenback; Revathy Iyer; Sharon Hymes; Adam P Dicker; Brigitte Miller; Beth Erickson; David K Gaffney
Journal:  Int J Gynecol Cancer       Date:  2012-01       Impact factor: 3.437

6.  Incidence of radiation toxicity in cervical cancer and endometrial cancer patients treated with radiotherapy alone versus adjuvant radiotherapy.

Authors:  Andrzej Roszak; Zaneta Wareńczak-Florczak; Krystyna Bratos; Piotr Milecki
Journal:  Rep Pract Oncol Radiother       Date:  2012-09-05

7.  The usefulness of an independent patient-specific treatment planning verification method using a benchmark plan in high-dose-rate intracavitary brachytherapy for carcinoma of the uterine cervix.

Authors:  Yutaka Takahashi; Masahiko Koizumi; Iori Sumida; Fumiaki Isohashi; Toshiyuki Ogata; Yuichi Akino; Yasuo Yoshioka; Shintaro Maruoka; Shinichi Inoue; Koji Konishi; Kazuhiko Ogawa
Journal:  J Radiat Res       Date:  2012-07-17       Impact factor: 2.724

8.  Stereotactic body radiation therapy via helical tomotherapy to replace brachytherapy for brachytherapy-unsuitable cervical cancer patients - a preliminary result.

Authors:  Chen-Hsi Hsieh; Hui-Ju Tien; Sheng-Mou Hsiao; Ming-Chow Wei; Wen-Yih Wu; Hsu-Dong Sun; Li-Ying Wang; Yen-Ping Hsieh; Yu-Jen Chen; Pei-Wei Shueng
Journal:  Onco Targets Ther       Date:  2013-02-04       Impact factor: 4.147

9.  Biological effective doses in the intracavitary high dose rate brachytherapy of cervical cancer.

Authors:  B Arunkumar Sharma; Th Tomcha Singh; L Jaichand Singh; Y Indibor Singh; Y Sobita Devi
Journal:  J Contemp Brachytherapy       Date:  2011-12-30

10.  Brachytherapy for cervix cancer: low-dose rate or high-dose rate brachytherapy - a meta-analysis of clinical trials.

Authors:  Gustavo A Viani; Gustavo B Manta; Eduardo J Stefano; Ligia I de Fendi
Journal:  J Exp Clin Cancer Res       Date:  2009-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.